Sequenom of San Diego has announced an agreement to sell its MassArray system to Metabion.
Terms of the deal were not disclosed.
Metabion of Munich will use the system to monitor its oligonucleotide production while providing Sequenom with a source for oligonucleotides, an element in assay development for genotyping technologies.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.